Trial intelligence / Profile preview

Topical gentamicin prophylaxis in elective incisional hernia repair

2018-001860-45Phase 4Active

Sponsor
Hospital Plató
Start
Jul 2019
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of gentamicin in surgical site infection (SSI) and bacterial disease (2 arms), sponsored by Hospital Plató. Primary endpoint: Incisional surgical site infection rate. Started Jul 2019; status: active.

02

Drugs

gentamicin
03

Conditions

surgical site infection (SSI)bacterial disease

Beyond the preview

Go deeper on 2018-001860-45.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-001860-45.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call